29.06.2012: Vortrag im Rahmen der Sommerschule „Marine Biotechnologie“

 um 12:15 Uhr im Gr. Konferenzraum (WEST), GEOMAR, Düsternbrooker Weg 20

 Dr. Fiona Chan is developing novel therapies for the treatment of atrial fibrillation using its proprietary platform of ion channel drug discovery and development. The Company is developing drug candidates that modulate two novel, but well characterized, ion channels and expects to develop breakthrough products in this area of huge unmet medical need. In addition, alliances were established with major pharmaceutical companies in areas outside These core interests.

www.xention.com

http://screeningport.com/